Used in research and development of immunotherapies targeting T-cell activation pathways. Blocks the interaction between CD28 on T-cells and CD80 (B7-1) on antigen-presenting cells, thereby modulating immune responses. Investigated for potential in treating autoimmune diseases and preventing transplant rejection by suppressing unwanted T-cell activation. Also serves as a reference standard in bioassays and antibody characterization studies for drug development.